Hypoparathyroidism 2025 Summit: Translating Science from the Laboratory to the Clinic

Question Title

* 1. Please rate the overall learning objectives of this summit.
I am able to:

  1-Strongly Disagree 2-Disagree 3-Neutral 4-Agree 5-Strongly Agree
Identify unmet needs in the diagnosis and medical management of hypoparathyroidism
Outline recent insights in Calcium-Sensor Receptor (CaSR) activation and the potential of calcilytics
Discuss advances in PTH basic research and corresponding clinical implications
Describe advances in cell therapies research and corresponding clinical implications

Question Title

* 2. Please provide feedback on the speakers for II. BACKGROUND

  Michael Mannstadt Aliya Khan Heide Siggelkow
The speaker presented information clearly.
The speaker was engaging and knowledgeable.
The speaker managed time effectively.
The speaker was credible and non-biased.
The speaker's slides were clear and concise.

Question Title

* 3. Please provide feedback on the speakers for III. CaSR AS A TARGET

  Hao Zuo Caroline Gorvin Ed Nemeth Kelly Roszko Wenhan Chang
The speaker presented information clearly.
The speaker was engaging and knowledgeable.
The speaker managed time effectively.
The speaker was credible and non-biased.
The speaker's slides were clear and concise.

Question Title

* 4. Please provide feedback on the speakers for IV. PTH PEPTIDES

  Karen Winer Bart Clarke Kennett Sprogøe Aliya Khan Richard DiMarchi
The speaker presented information clearly.
The speaker was engaging and knowledgeable.
The speaker managed time effectively.
The speaker was credible and non-biased.
The speaker's slides were clear and concise.

Question Title

* 5. Please provide feedback on the speakers for V. PTH1R AS A TARGET

  Thomas Gardella Maria Luisa Brandi
The speaker presented information clearly.
The speaker was engaging and knowledgeable.
The speaker managed time effectively.
The speaker was credible and non-biased.
The speaker's slides were clear and concise.

Question Title

* 6. Please provide feedback on the speakers for VI. CELL THERAPIES & PARATHYROID TRANSPLANT

  Michael Levine Diane Krause
The speaker presented information clearly.
The speaker was engaging and knowledgeable.
The speaker managed time effectively.
The speaker was credible and non-biased.
The speaker's slides were clear and concise.

Question Title

* 7. Were you able to identify any CanMEDS roles other than Medical Expert in the session? Check all that apply.
CanMEDS roles describe the abilities physicians require to effectively meet the health care needs of the people they serve. Read more about CanMEDS.

Question Title

* 8. Please list 3 things you will do differently as a result of attending this session.

Question Title

* 9. Please rate your overall experience of Hypoparathyroidism 2025 Summit: Translating Science from the Laboratory to the Clinic:

  1-Strongly Disagree 2-Disagree 3-Neutral 4-Agree 5-Strongly agree
The content was pertinent to my practice.
There was adequate time for questions & interaction.
Potential conflicts of interest were divulged.
Generic names were used consistently.
I did not perceive any commercial bias.

Question Title

* 10. What elements did you like about the session?

Question Title

* 11. What elements did you dislike about the session?

Question Title

* 12. Please share other topic suggestions or learning needs for future sessions.

Please click the "Submit" button to access the Certificate of Attendance LINK on the next page.

T